Please assess the completion status of the following clinical trial:

Trial Title: Effects of the Quantity of Repetitive Transcranial Magnetic Stimulation(rTMS) on the Recovery After Stroke

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2/PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* single mono-hemispheric ischemic or hemorrhagic stroke~* 1st onset stroke patient~* Upper extremity functional deficit attributable to acute stroke~* A stage of at least 3 on brunnström pre-treatment~* Written signed consent~Exclusion Criteria:~* Multiple lesion~* Bilateral cortical lesion and motor problems~* Cerebellar, or brainstem lesions~* History of more than one stroke~* Uncontrolled medical problems, such as: cardiopulmonary disease, severe rheumatoid arthritis, active joint deformity of arthritic origin, active cancer, or renal disease;~* Increased intracranial pressure~* History of seizure confirmed by interview and medical chart review~* Any individual who is on medication which is known to lower seizure threshold~* Other conditions that increase the risk of side effects due to rTMS procedures: a metal plate or metal object in the skull or eye, intracardiac line, increased intracranial pressure, cardiac pacemaker, implanted medication pump, tricyclic antidepressants, neuroleptics, history of seizure in the immediate family~* An age of less than 20 years old~* Any current actively treated medical or surgical condition or neurological or psychiatric illness other than stroke~* Complications that would prevent participation in the intervention, such as severe pain and severe spasticity~* Inability to cooperate outcome measure-related task~* Severe language disturbances~* Serious cognitive deficits~* Non-vascular cause for the neurological symptoms other central nervous system~* Disorder or peripheral neuropathy of the upper extremity~* Taking medication which interrupt brain activity~* Women who are pregnant

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Sham rTMS-Sham rTMS (Type: SHAM_COMPARATOR): Sham rTMS for 2 weeks
- Sham rTMS-Real rTMS (Type: EXPERIMENTAL): Sham rTMS in the first week and real rTMS in the second week
- Real rTMS-Real rTMS (Type: EXPERIMENTAL): Real rTMS for 2 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).